Iron Supplementation for an 8-Year-Old Child (26.6 kg)
For routine oral iron supplementation in an 8-year-old child weighing 26.6 kg with iron deficiency anemia, administer 3 mg/kg/day of elemental iron (approximately 80 mg elemental iron daily), given as ferrous sulfate, preferably in the morning on an empty stomach with vitamin C to enhance absorption.
Dosing Algorithm
Standard Treatment Dose
- Calculate dose: 3 mg/kg/day of elemental iron 1, 2
- For this child: 26.6 kg × 3 mg/kg = approximately 80 mg elemental iron daily
- Formulation: Use ferrous sulfate as the preferred oral iron salt 3
Optimal Administration
- Timing: Morning dose on an empty stomach 3
- Co-administration: Give with approximately 100 mg vitamin C (tablet or citrus juice like orange juice) to maximize absorption 3
- Avoid: Do not give with milk, tea, coffee, cereals, grains, calcium supplements, or antacids as these markedly reduce absorption 3
- Position: Patient should remain upright for 30-60 minutes after dosing to prevent pill esophagitis 3
Duration of Treatment
Treatment should continue for 2-3 months total 2:
- Initial assessment: Check hemoglobin after 4 weeks
- Confirmation: A rise in hemoglobin >1 g/dL confirms iron deficiency 2
- Continuation: Continue for 2 additional months to replenish iron stores 2
- Follow-up: Recheck hemoglobin at end of treatment and again 6 months later 2
Recent evidence suggests that shorter durations (<3 months) may be as effective as longer durations when baseline anemia is controlled for, with the highest effect size of 2.39 g/dL hemoglobin improvement 4. However, ferritin levels (iron stores) increase more with longer supplementation 5.
Dosing Considerations Based on Recent Evidence
Dose Categories
Recent meta-analyses show that low-dose supplementation (<5 mg/kg/day) demonstrates favorable trends, particularly in children with lower baseline hemoglobin levels 4. However, moderate-dose supplements (which includes the standard 3 mg/kg/day) are more effective than low-dose at improving hemoglobin, ferritin, and iron deficiency anemia 5.
Alternative Regimens
- Intermittent dosing (1-2 times weekly) shows similar efficacy to daily dosing for reducing anemia, though ferritin increases more with frequent supplementation 5
- Alternate-day dosing may improve fractional iron absorption and reduce adverse effects 3
Formulation Options
Preferred: Ferrous Sulfate
- Most commonly used and studied
- Provides 2.03 g/dL hemoglobin improvement 4
Alternative: Ferrous Ascorbate
- May provide higher hemoglobin rise (3.59 g/dL vs 2.43 g/dL for colloidal iron) 1
- Contains built-in vitamin C for enhanced absorption
- 64.86% of children became non-anemic vs 31.03% with colloidal iron 1
Important Caveats
When Oral Iron is Insufficient
The provided guidelines primarily address parenteral iron in children receiving parenteral nutrition, which is not the typical scenario for an otherwise healthy 8-year-old [6-6]. These guidelines emphasize:
- Enteral route is preferred when tolerated 6
- Parenteral iron should be reserved for long-term PN patients who cannot maintain adequate iron status with oral supplements 6
Monitoring
- Baseline: Hemoglobin and ferritin
- Week 4: Hemoglobin (should rise >1 g/dL)
- End of treatment: Hemoglobin and ferritin
- 6 months post-treatment: Hemoglobin
Common Pitfalls to Avoid
- Poor absorption: Giving iron with food, milk, or calcium-containing products
- Inadequate duration: Stopping treatment when hemoglobin normalizes without replenishing iron stores
- Wrong formulation: Using ferric salts instead of ferrous salts (ferrous forms are better absorbed orally)
- Timing errors: Afternoon dosing reduces absorption compared to morning dosing 3
Practical Prescription Example
Ferrous sulfate 325 mg tablets (containing approximately 65 mg elemental iron):
- Give 1 tablet daily in the morning
- Take on empty stomach with orange juice or vitamin C tablet
- Wait 1 hour before eating breakfast
- Continue for 3 months total
- Recheck hemoglobin at 4 weeks
This approach balances efficacy with tolerability and aligns with both traditional dosing recommendations 2 and recent evidence supporting moderate-dose, shorter-duration regimens 4, 5.